BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7683585)

  • 1. Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide.
    Wakiyama H; Tsuru S; Hata N; Shinomiya M; Shinomiya N; Noritake M; Umezawa Y; Rokutanda M
    Clin Exp Immunol; 1993 May; 92(2):218-24. PubMed ID: 7683585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long survival of leukemic mice by repeated combination treatment of cyclophosphamide and recombinant human granulocyte colony-stimulating factor.
    Tamura M; Nomura H; Ono M; Bessho M; Hirashima K
    Leukemia; 1991 Dec; 5(12):1043-9. PubMed ID: 1723131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
    Misaki M; Ueyama Y; Tsukamoto G; Matsumura T
    Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance.
    Hamood M; Bluche PF; De Vroey C; Corazza F; Bujan W; Fondu P
    Mycoses; 1994; 37(3-4):93-9. PubMed ID: 7531290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by polyethylene glycol on anticancer drug-induced neutropenia in mice.
    Ishikawa M; Okada Y; Satake-Ishikawa R; Kakitani M; Kawagishi M; Matsuki S; Kusaka M; Asano K
    Gen Pharmacol; 1994 May; 25(3):533-7. PubMed ID: 7523237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
    Matsuzaki G; Li XY; Ohyama Y; Nomoto K
    Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination effect of KW-2228 and cephem antibiotics in a systemic infection model in neutropenic mice].
    Yoshino T; Sato K
    Jpn J Antibiot; 1992 Jan; 45(1):106-11. PubMed ID: 1379649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of human granulocyte colony-stimulating factor on bacterial and fungal infections in neutropenic mice.
    Ono M; Matsumoto M; Matsubara S; Tomioka S; Asano S
    Behring Inst Mitt; 1988 Aug; (83):216-21. PubMed ID: 2467649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chemotherapy-induced neutropenia in children with subcutaneously administered recombinant human granulocyte colony-stimulating factor.
    Okamura J; Yokoyama M; Tsukimoto I; Komiyama A; Sakurai M; Imashuku S; Miyazaki S; Ueda K; Hanawa Y; Takaku F
    Pediatr Hematol Oncol; 1992; 9(3):199-207. PubMed ID: 1381941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (rG-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone.
    Matsumoto M; Matsubara S; Yokota T
    J Antimicrob Chemother; 1991 Sep; 28(3):447-53. PubMed ID: 1720432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS.
    Vecchiarelli A; Monari C; Baldelli F; Pietrella D; Retini C; Tascini C; Francisci D; Bistoni F
    J Infect Dis; 1995 Jun; 171(6):1448-54. PubMed ID: 7539473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of biological response modifiers against pulmonary candidiasis in neutropenic mice].
    Futenma M; Higa F; Zhang KX; Kusano N; Saito A
    Kansenshogaku Zasshi; 1994 Apr; 68(4):513-9. PubMed ID: 7517987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of the acute phase response after infection in cyclophosphamide-treated mice by granulocyte colony-stimulating factor.
    Sawaki M; Kita E; Mikasa K; Konishi M; Kumimatsu M; Kashiba S; Narita N
    Biotherapy; 1993; 6(1):51-61. PubMed ID: 7685182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the prophylactic and therapeutic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by pseudomonas aeruginosa in neutropenic mice].
    Tanaka N; Kumamoto Y; Hirose T; Yokoo A
    Kansenshogaku Zasshi; 1989 Feb; 63(2):145-55. PubMed ID: 2473150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
    Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
    Hattori K; Orita T; Oheda M; Tamura M; Ono M
    In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia.
    Bernini JC; Wooley R; Buchanan GR
    J Pediatr; 1996 Oct; 129(4):551-8. PubMed ID: 8859262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in total blood leukocyte count following intranasal administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rabbits with cyclophosphamide-induced leukopenia.
    Watanabe Y; Kikuchi R; Kiriyama M; Nakagawa K; Oe J; Nomura H; Maruyama K; Matsumoto M
    Biol Pharm Bull; 1995 Aug; 18(8):1084-8. PubMed ID: 8535401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.